1. Aetna considers certain procedures/services medically necessary for the evaluations of members with unexplained olfactory dysfunction (e.g., anosmia, hyposmia, dysosmia) and gustatory dysfunction (e.g., ageusia, hypogeusia, dysgeusia):
   
   
   1. Biopsy of the olfactory mucosa
   2. Drug assays and chemical analyses when certain medications or nutritional deficiencies are the suspected causes of the disorders
   3. Electroencephalography (EEG) for members with a history of seizures
   4. Hematological tests (e.g., hematocrit count, hemoglobin level, white blood cell count, urea nitrogen level, creatinine level, glucose level, erythrocyte sedimentation rate, eosinophil count, and immunoglobulin E level)
   5. Medical evaluation (complete medical history and physical examination)
   6. Nasal endoscopy
   7. Neuroimaging with computed tomography (CT) or magnetic resonance imaging (MRI) to rule out an intra-cranial or peripheral nerve abnormality
   8. Neurological consultation
   9. Otolaryngological consultation
   10. Psychiatrical consultation
   11. Standard taste tests such as Taste-Threshold Test (also known as Whole-Mouth Taste-Threshold Test), Taste-Suprathreshold Test, Taste-Quadrant Test, and Flavor Discrimination Test (for evaluation of both taste and smell sensation)
   12. Standardized olfactory tests such as the UPSIT or “Sniffin' Sticks”, the University of Connecticut Test Battery, the Pocket Smell Test, or the Brief Smell Identification Test. Other tests include Smell-Threshold Test, Smell-Suprathreshold Test, and Smell Unilateral Test.  For use of olfactory testing in Parkinson disease, see CPB 0307 - Parkinson's Disease 
   13. Thyroid function studies.
       

   Note: An initial and follow-up visit is considered medically necessary for smell and/or taste dysfunction testing.  Additional visits for testing are considered not medically necessary.

   Note: Members with taste loss may need smell testing in addition to taste testing.

2. Aetna considers the following services as a means of diagnosing an unexplained olfactory dysfunction experimental and investigational because the peer-reviewed medical literature does not support the use of these studies for this indication:
   
   
   1. Electrogustometry
   2. Olfactometry 
   3. Olfactory and gustatory event potentials (see CPB 0181 - Evoked Potential Studies)
   4. Positron emission tomography (PET) (see CPB 0071 - Positron Emission Tomography (PET))
   5. Rhinomanometry (see CPB 0700 - Rhinometry and Rhinomanometry)
   6. Rhinometry (also known as acoustic rhinometry) (see CPB 0700 - Rhinometry and Rhinomanometry)
   7. Single photon emission computed tomography (SPECT) (see CPB 0376 - Single Photon Emission Computed Tomography (SPECT))

Normal olfactory and gustatory functioning plays a key role in nutrition and food selection, and thus is important for the maintenance of a good quality of life.  Smell and taste are closely inter-related.  An impairment of the function of one sense often affects the function of the other sense.  In fact, complaints of gustatory loss usually reflect smell rather than taste dysfunction.  Deficits in these senses not only can reduce the pleasure and comfort from food, but can also lead to food poisoning or over-exposure to environmentally hazardous agents that are otherwise detectable by smell and taste.

More than 2 millions Americans suffer from smell and taste disorders.  Olfactory dysfunction is more common than gustatory dysfunction because of the vulnerability and anatomical distinctiveness of the olfactory system, and because a decline in olfactory function is part of the normal aging process.  Common olfactory and gustatory disturbances could be the consequence of a variety of medications, upper respiratory infections, nasal and paranasal sinus diseases, depression, hypothyroidism, and damage to peripheral nerves supplying smell and taste.  In particular, inflammation (nasal and sinus disease), viral infection, and head trauma are the most frequent causes of smell disorders; while oral and perioral infections (e.g., gingivitis and candidiasis), oral appliances (e.g., dentures and filling materials), dental procedures and Bell's palsy are the most common causes of taste disorders.

Anosmia refers to an absence of the smell sensation; hyposmia is defined as reduced sensitivity to odorants (odor stimuli), and dysosmia refers to an altered perception of smell.  Dysosmia can be further classified into phantosmia (a perception of an odor without the stimulus present) and parosmia or troposmia (an altered perception of an odor with a stimulus present).

Ageusia refers to an absence of the taste sensation; hypogeusia is defined as reduced sensitivity to tastants (taste stimuli), and dysgeusia refers to an altered perception to taste with or without the presence of a tastant.

A careful medical history of systemic illnesses and medication use as well as a thorough physical examination are essential for the diagnosis of smell and taste disorders.  Work-up should not commence until a standardized test such as the University of Pennsylvania Smell Identification Test (UPSIT) or the University of Connecticut Test Battery has been given to establish impairment of the sense of smell.  The University of Pennsylvania Smell Identification Test (UPSIT) is an objective, quantitative test of olfactory function.  The test consists of 40 odors, each of which is microencapsulated on a pad that, one at a time, the patient scratches with a pencil and sniffs.  The patient is provided with a list of 4 choices for each pad, and from which the correct answer must be chosen or a guess made.  It has been demonstrated that there is good correlation between UPSIT and other olfactory function tests such as the T&T olfactometer threshold test, Cain's odor identification test, and Le Nez du Vin-derived smell identification test.  Furthermore, it has been reported that the UPSIT and its 10-, 20-, and 30-item fragments have very high internal consistency reliability.

The recent practice parameter on diagnosis and prognosis of new onset Parkinson disease by the American Academy of Neurology (Suchowersky et al, 2006) stated that olfactory testing using either the UPSIT or “Sniffin' Sticks” should be considered to differentiate progressive supranuclear palsy and corticobasal degeneration from Parkinson's disease.

Nasal mucous membranes should be examined for abnormal conditions.  Biopsy is necessary if intra-nasal or intra-oral neoplasm is suspected to be the cause of the dysfunction.  Furthermore, intra-nasal biopsy is also helpful in diagnosing post-upper respiratory infection-induced olfactory loss.  Drug assays, chemical analyses and thyroid function studies may be necessary since distortion of chemosensory sensations are associated with the use of certain medications (e.g., anti-depressants and anti-convulsants, anti-psychotics, anti-hypertensives and cardiac medications, lipid-lowering agents, and anti-Parkinsonian agents), nutritional deficiency (e.g., zinc deficiency), and thyroid disease.

Neuroimaging such as CT or MRI may be necessary to rule out intra-cranial or peripheral nerve abnormalities.  Computed tomography is useful in imaging the nasal and sinus cavities, skull base, olfactory cleft, nasopharynx, parotid, oropharynx, neck, and mandible.  Bone abnormalities and widening of cranial nerve foramina are best observed with CT.  Magnetic resonance imaging is useful in evaluating the olfactory bulbs, ventricles, other soft tissues in the brain, soft tissues of the tongue, tongue base, blood vessels and nerves in the skull base and neck.  Studies such as SPECT and PET do not play a significant role in the diagnosis of olfactory and gustatory dysfunctions.  Patients with a history of seizure disorder should be referred for EEG.  Otolaryngological, neurological, and psychiatrical consultation may be necessary if the underlying cause of the olfactory/gustatory dysfunction is diagnosed as a condition, which may require further evaluation and treatment, by a specialist in such discipline.

Ellegard and colleagues (2007) examined if electrogustometry is useful for screening abnormalities of taste.  These investigators asked 114 subjects, some healthy but most with medical conditions possibly affecting taste, to rate their overall taste ability, on a scale of 0 to 10.  Those who had current symptoms related to taste, and who rated their taste as 5 or worse were defined as "aberrant tasters".  These researchers recorded automated electrogustometry thresholds, and visual analog scale intensity ratings, for solutions of the four basic tastes (sweet, sour, salty and bitter).  A visual analog scale score of 50 was used as a cut-off point to identify "poor tasters".  The sensitivity and specificity of electrogustometry in identifying abnormal taste function were low.  The authors concluded that automated electrogustometry is not a useful clinical screening method for taste disturbance in this group of subjects.

There is insufficient scientific evidence to support the usefulness of olfactory evoked potentials, olfactometry, rhinometry, rhinomanometry, or electrogustometry in the diagnosis of smell and taste disorders.